drugset / Trial / NCT01354483
Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury
Phase 1/2
Completed
20 enrolled
China Spinal Cord Injury Network
Chengdu PLA General Hospital · collab
RandomizedFactorialOpen-labelTreatment
Summary
The purpose of this study is to investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood mononuclear cell transplant in the treatment of chronic spinal cord injuries.
Timeline
- Start
- 2011-09
- Primary completion
- 2013-09
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Umbilical Cord Blood Mononuclear Cell | Cell therapy | 1.6e+06 cells | Other |
| Subject | Umbilical Cord Blood Mononuclear Cell | Cell therapy | 3.2e+06 cells | Other |
| Subject | Umbilical Cord Blood Mononuclear Cell | Cell therapy | 6.4e+06 cells | Other |
| Background | Lithium Carbonate | Unknown | — | Oral |
| Background | Methylprednisolone | Other / unclassified | 30 mg/kg | Intravenous |